PRESS RELEASE published on 09/02/2025 at 13:00, 8 months 10 days ago Moderna Announces Data to be Presented at the 2025 International Congress of Inborn Errors of Metabolism Moderna, Inc. to present abstracts on mRNA therapeutics at the 2025 ICIEM including PA, MMA, and GSD1a programs in Kyoto, Japan. Company's first time presenting data for MMA and GSD1a Moderna Inc. MRNA Therapeutics ICIEM Abstracts Kyoto Japan
BRIEF published on 08/27/2025 at 19:29, 8 months 15 days ago Les vaccins Moderna contre la COVID-19 mis à jour approuvés par la FDA américaine Approbation De La FDA Moderne Vaccin Contre Le Covid-19 Variante Du SRAS-CoV-2 Spikevax Et MNEXSPIKE
BRIEF published on 08/27/2025 at 19:29, 8 months 15 days ago Moderna's Updated COVID-19 Vaccines Approved by U.S. FDA FDA Approval COVID-19 Vaccine Moderna SARS-CoV-2 Variant Spikevax And MNEXSPIKE
PRESS RELEASE published on 08/27/2025 at 19:24, 8 months 15 days ago Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccines Targeting LP.8.1 Variant of SARS-CoV-2 Moderna announces FDA approval for updated Spikevax® and mNEXSPIKE® COVID-19 vaccines targeting LP.8.1 variant to prevent severe outcomes. Vaccines available soon FDA Approval Moderna COVID-19 Vaccines Spikevax MNEXSPIKE
BRIEF published on 08/22/2025 at 15:30, 8 months 20 days ago Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine COVID-19 Vaccine Moderna Health Canada Approval Canadian Manufacturing Biomanufacturing Leadership
BRIEF published on 08/22/2025 at 15:30, 8 months 20 days ago Moderna reçoit l'approbation de Santé Canada pour son vaccin contre la COVID-19 mis à jour Moderne Vaccin Contre Le Covid-19 Fabrication Canadienne Approbation De Santé Canada Leadership En Bioproduction
PRESS RELEASE published on 08/22/2025 at 15:25, 8 months 20 days ago Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1 Moderna's Spikevax COVID-19 vaccine for SARS-CoV-2 LP.8.1 variant authorized in Canada, with all 2025 doses produced domestically. Leadership in biomanufacturing highlighted COVID-19 Vaccine Canada Moderna Spikevax Biomanufacturing
BRIEF published on 08/21/2025 at 13:05, 8 months 22 days ago Moderna participera aux principales conférences de septembre 2025 Conférences D'investisseurs Moderne Webcast En Direct Médecine À Base D'ARNm Présentation Des Soins De Santé
BRIEF published on 08/21/2025 at 13:05, 8 months 22 days ago Moderna to Participate in Major September 2025 Conferences Investor Conferences MRNA Medicine Moderna Live Webcast Healthcare Presentation
PRESS RELEASE published on 08/21/2025 at 13:00, 8 months 22 days ago Moderna to Present at Upcoming Conferences in September 2025 Moderna, Inc. to participate in upcoming investor conferences. The company's innovative mRNA technology redefines medicine creation, focusing on infectious diseases, oncology, and more Investor Conferences Healthcare COVID-19 Vaccine MRNA Technology Moderna
Published on 05/12/2026 at 14:30, 28 minutes ago Pathfinder Ventures Inc. Announces Conclusion of Financing and Intention to Launch New Private Placement
Published on 05/12/2026 at 13:50, 1 hour 8 minutes ago Polaris Renewable Energy Announces Approval of SO1 Agreement by FOMB
Published on 05/12/2026 at 13:30, 1 hour 28 minutes ago Silver X Mining Begins Trading on OTCQX, Expanding Access to U.S. Investors
Published on 05/12/2026 at 13:30, 1 hour 28 minutes ago Electric Metals Launches Preliminary Economic Assessment for North Star Manganese Project Downstream HPMSM and EMM Processing Facilities
Published on 05/12/2026 at 14:35, 23 minutes ago n8n valuation doubles to $5.2bn as SAP makes strategic investment and plans to embed the AI platform into Joule Studio
Published on 05/12/2026 at 14:30, 28 minutes ago Delticom publishes Q1 business development: Focus on profitability, consolidated net income remains steady
Published on 05/12/2026 at 14:30, 28 minutes ago New Energy Model “From the Region for the Region”: Utility, Industry and Citizens Invest in Local Battery Storage
Published on 05/12/2026 at 14:29, 29 minutes ago Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc
Published on 05/12/2026 at 14:10, 48 minutes ago LNA SANTE : Répartition de capital et des droits de vote attachés aux actions au 11/05/2026
Published on 05/12/2026 at 08:30, 6 hours 28 minutes ago Eiffage annonce le démarrage des travaux de construction du pôle universitaire du campus Grand Paris Nord à Saint-Ouen-sur-Seine
Published on 05/12/2026 at 08:30, 6 hours 28 minutes ago Eiffage announces launch of the construction work on the university hub of the Grand Paris Nord campus in Saint-Ouen-sur-Seine
